Within the global context of increasing poverty in the developing countries, natural products are important in devising new drugs. Vicia ervilia L. Willd., unlike several fabaceae seeds, is not used for human consumption till now. We aim to discover any possible medicinal use of the seed. Analgesic, anti-inflammatory, antiulcerogenic and antihyperglycemic activities were evaluated using hot plate, carrageenan-induced rat paw edema, ethanol-induced ulcer model and alloxan-induced diabetes methods, respectively. Antiviral activity was evaluated using Methylthiazol Tetrazolium assay. V. ervilia seeds ethanol (70%) extract had significant anti-inflammatory, analgesic, antiulcerogenic, antihyperglycemic and antiviral activities. It is of excellent choice for treatment of several illnesses in developing countries due to its diverse resource, easy accessibility, affordability and its newly proved significant wide range of biological activities.
PUBLIC INTEREST STATEMENT
Within the global context of increasing poverty in the developing countries, natural products are important in devising new drugs. Vicia ervilia seeds are not used for human consumption till now although it is well known as an excellent sheep and cattle feed concentrate. This perspective article discovers some possible medicinal use of the seed. Analgesic, anti-inflammatory, antiulcerogenic, antihyperglycemic, and antiviral activities were evaluated. These treasure seeds are of excellent choice for treatment of several illnesses for lowincome people in developing countries due to its diverse resource, easy accessibility, affordability and its newly explored wide range of biological activities.
Extract preparation
Seeds were powdered and extracted with ethanol (70%) by percolation at room temperature for three consecutive days. The solvent was evaporated under vacuum to yield seeds ethanol (70%) extract (SEE).
Biological activities
Animals: were obtained from the animal house of the Laboratory National Research Center, Giza, Egypt. They were kept on standard laboratory diet. This study was conducted in accordance with ethical procedures and policies approved by Animal Care and Use Committee of Faculty of Pharmacy, Cairo University which follows the World Medical Association Declaration of Helsinki (WMA General Assembly 1964).
Determination of median lethal dose (LD50): was estimated according to (Kerber, 1931) .
Acute anti-inflammatory activity: carrageenan-induced rat paw edema method was followed (Winter, Risley, & Nuss, 1962) . Hind paw volume was measured by water displacement method using 7410, Ugo Basile, plythesmometer, Comerio, Italy (Chattopadhyay et al., 2002; Li, Hyun, Jeong, Kim, & Lee, 2003) . Indomethacin (Epico, Egyptian Int. Pharmaceutical Industries Co.) was used as a positive control.
Analgesic activity: Hot plate method was carried out using (7280 Ugo Basile Biological Research Apparatus Company, Comerio, Italy) according to (Laviola & Alleva, 1990; Woolfe & McDonald, 1944) . Indomethacin was used as a positive control.
Antiulcerogenic activity: ethanol-induced ulcer model was adopted (Morimoto, Shimohara, Oshima, & Sukamoto, 1991) . Ranitidine was used as a reference drug. Lesions were examined under an illuminated magnifier (Adami, Marazzi-Uberti, & Turba, 1964) .
Antihyperglycemic activity: The technique used by (Zhang, Huang, Hou, & Wang, 2006 ) was followed. Hyperglycemia was induced by alloxan monohydrate (Sigma Co., USA). BioMerieux kits were used for the assessment of blood glucose, triglycerides and cholesterol levels.
Antiviral activity: VERO cells (kidney epithelial cells of African green monkey) incubated into culture bottle were checked using inverted microscope. Healthy cells propagation, determination of extract cytotoxicity and MTT assay protocol were done according to (Alley, Scudiero, & Monks, 1988; Van de Loosdrecht, 1994) .
Results and discussion
The LD 50 of seed ethanol extract (SEE) was up to 5 g/kg b.wt. It is thus of high safety margin at the tested dose level (Buck, Osweiter, & Van Gelder, 1976) . These reflect the possibility of the plant use for nutritional or medicinal purposes after elimination of its anti-nutritional factor canavanine (Berger, Robertson, & Cocks, 2003; Sadeghi, Samie, Pourreza, & Rahmani, 2004) .
SEE showed a significant anti-inflammatory activity (p < 0.05). When indomethacin was administered the edema volume after 4 h of carrageenan injection was 24.5% of its original volume. The edema volume was 46.51% of its original volume when SEE was tested (500 mg/kg). The extract did not cause gastric ulcers, during the course of study, as usually happens with anti-inflammatory drugs. SEE showed a significant analgesic activity. SEE (500 mg/kg) analgesic activity was 80.21% of indomethacin (Table 1) . SEE showed a pronounced antiulcerogenic activity (Table 2) . SEE (250 mg/kg) reduced ulcers number and severity by 80.6 and 82.32%, respectively. The antiulcerogenic activity at 500 mg/kg approached that of ranitidine. SEE caused significant (p < 0.05) reduction in glucose, triglycerides, and cholesterol levels of hyperglycemic rats (Table 3) 
Control
Indomethacin SEE The Antiviral activity was screened against Coxsackie B4 virus. It is a serotype of Enterovirus B which can trigger an autoimmune reaction resulting in destruction of the pancreas insulin-producing beta cells, which is one of several different etiologies of diabetes mellitus (Ylipaasto et al., 2004) . SEE had a mild activity against Coxsackie B4 virus (Table 4) . SEE proved to have significant hypoglycemic action in this study (Table 3 ). This suggests the use of V. ervilia seeds in treatment of diabetes as it may relieve the case through two different mechanisms, antiviral and hypoglycemic ones. Further studies on the ability of V. ervilia seeds to treat diabetes through other mechanisms as increased 
